| Identification | Back Directory | [Name]
GPR84 antagonist 9 | [CAS]
2654791-96-3 | [Synonyms]
GPR84 antagonist 9
2H-Furo[2,3-g]indazole-7-carboxamide, N-[(5-cyclopropyl-2-pyrazinyl)methyl]-2-[(2S)-1,4-dioxan-2-ylmethyl]-4,5-dihydro-4-methyl-8-(trifluoromethyl)-, (4R)- | [Molecular Formula]
C25H26F3N5O4 | [MOL File]
2654791-96-3.mol | [Molecular Weight]
517.5 |
| Chemical Properties | Back Directory | [Boiling point ]
669.989±55.00 °C(Press: 760.00 Torr)(predicted) | [density ]
1.602±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | [pka]
11.995±0.40(predicted) |
| Hazard Information | Back Directory | [Uses]
GPR84 antagonist 9 (compound 320) is an orally active GPR84 antagonist with the IC50 of 0.012 μM. GPR84 antagonist 9 can be used for study of inflammatory-driven pain diseases[1]. | [References]
[1] Frank Sacher, et al. Furoindazole derivatives for the treatment of pain. WO2024083705A1. 2024-04-25. |
|
|